Justin Silver is the Founder and CEO of SymptoGuard, a leading supplement for managing GLP-1 medication side effects, since 2024. As Managing Partner of American International Home Investments, a real estate private equity firm, Justin oversees a portfolio of over $25 million in residential real estate. Additionally, Justin co-founded and serves on the board of AAVRANI, a beauty brand that has raised over $15 million in funding. As a Venture Advisor at the Tsai Center for Innovative Thinking at Yale and Entrepreneur in Residence at Venture Lab, Justin supports emerging entrepreneurs. Justin also serves as a guest lecturer on entrepreneurship at prestigious institutions including Wharton, Yale, and NYU Stern. An active investor, Justin has stakes in companies such as Cadence, DEUX, FirstLook, and Banza. Justin holds an MBA with honors from The Wharton School and a BS in Management and Finance from NYU Stern, along with additional studies abroad in China.
This person is not in the org chart
This person is not in any teams
This person is not in any offices